Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02759822
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Leonardo Javier Arcuri 30
Very early researchUnknownNCT05528354
What this trial is testing

Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients

Who this might be right for
Hematopoietic Stem Cell TransplantationTP53
Zhejiang University 58
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Large-scale testing (Phase 3)Study completedNCT01296503
What this trial is testing

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 213
Testing effectiveness (Phase 2)Study completedNCT03359980
What this trial is testing

Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer

Who this might be right for
Fecal Microbiota Transplantation
MaaT Pharma 24
Not applicableUnknownNCT01008683
What this trial is testing

Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

Who this might be right for
H1N1 Influenza
Hadassah Medical Organization 300
Not applicableLooking for participantsNCT02161783
What this trial is testing

Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation

Who this might be right for
Primary Graft FailureSecondary Graft Failure
Masonic Cancer Center, University of Minnesota 50
Not applicableLooking for participantsNCT07688759
What this trial is testing

CMV-CMI in csCMVi After HSCT

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)Immune Reconstitution
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)UnknownNCT06075927
What this trial is testing

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Who this might be right for
CMV InfectionEBV InfectionStem Cell Transplant
Peking University People's Hospital 29
Early research (Phase 1)Ended earlyNCT01421927
What this trial is testing

Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Bordeaux 13
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)Study completedNCT00003148
What this trial is testing

Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 86
Early research (Phase 1)Study completedNCT02510417
What this trial is testing

Allogeneic Virus-specific T Cell Lines (VSTs)

Who this might be right for
Viral Infections After HSCT
Catherine Bollard 31
Testing effectiveness (Phase 2)WithdrawnNCT05222438
What this trial is testing

Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant

Who this might be right for
Relapsed Diffuse Large B-cell Lymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00046852
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
InfectionMultiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Not applicableStudy completedNCT02108522
What this trial is testing

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant

Who this might be right for
Infection
AlloVir 82
Large-scale testing (Phase 3)Ended earlyNCT00117702
What this trial is testing

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Who this might be right for
Graft vs Host Disease
Technische Universität Dresden 24
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Testing effectiveness (Phase 2)Study completedNCT02806375
What this trial is testing

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyeloproliferative Disorders
St. Petersburg State Pavlov Medical University 20
Next Page